Amgen submits new data to challenge FDA's proposal to withdraw Tavneos - Reuters
Amgen submits new data to challenge FDA's proposal to withdraw Tavneos Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxOUjFOZVhGVDhzc0liUGtnT1l4cUhiNEhydWJlc2xjYzkwT2pnNW9WN3BFZUdMdUlFek9yand6MDlZaEJoTi1PRmJnRml0SDI2R19lbk80SnZraElodV90UEF1ZEs3bjEwRk5wMHNWUm9NaVp3bnFxNkM3RTAzNzRNckEycTFYemNmYjdoT2JfaTZEQm9tWTdSNGVhMXhHeC1tVTdtdGpwc1RobVdVakRqZGZsbExxRkE?oc=5" target="_blank">Amgen submits new data to challenge FDA's proposal to withdraw Tavneos</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Humana agrees not to reference Teva's Israel ties at US drug trial - Reuters
Humana agrees not to reference Teva's Israel ties at US drug trial Reuters
August 13, 2026 at 03:33 PMNovartis defeats UK court bid to invalidate blockbuster drug Entresto patent - Reuters
Novartis defeats UK court bid to invalidate blockbuster drug Entresto patent Reuters
August 13, 2026 at 09:31 PMCapricor shares skyrocket as FDA agrees to review new Duchenne drug data - Reuters
Capricor shares skyrocket as FDA agrees to review new Duchenne drug data Reuters
August 14, 2026 at 10:41 AMLawsuit against Bristol Myers over delayed cancer drug is revived - Reuters
Lawsuit against Bristol Myers over delayed cancer drug is revived Reuters
August 13, 2026 at 06:00 PMUS FDA approves Regeneron's rare bone disorder drug - Reuters
US FDA approves Regeneron's rare bone disorder drug Reuters
August 19, 2026 at 06:53 PMVIEW Moderna-Merck melanoma vaccine data boosts outlook, but analysts await full results - Reuters
VIEW Moderna-Merck melanoma vaccine data boosts outlook, but analysts await full results Reuters
August 19, 2026 at 02:45 PM